SecBot SecBot
6-K ·Filed Aug 25, 2026

AZN

ASTRAZENECA PLC
NEUTRAL
Impact 3/10
Horizonweeks Processed2mo ago SEC0001654954-26-007840
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine refinancing/liquidity move for a $257B company. Monitor upcoming earnings for any shift in leverage or capital allocation strategy, but no immediate trading catalyst.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$169.66
T+0 close · Aug 25, 2026 · via day close
Latest settled
−3.73%
T+20 · $163.33 · next T+60 tomorrow
Vs SPY
−4.71%
α at T+20
Latest observation
+10.84%
T+57 · FF3 residual α
  1. T+0 · Aug 25 $169.66entry
  2. T+1 · 3mo ago −2.00%α −2.02% · $166.27
  3. T+5 · 3mo ago −4.24%α −3.70% · $162.47
  4. T+20 · 8w ago −3.73%α −4.71% · $163.33
  5. T+58 · todayOpen
  6. T+60 · tomorrow Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

AstraZeneca priced a €2.55 billion bond offering across four tranches via its subsidiary AstraZeneca Finance LLC, with proceeds for general corporate purposes. The debt issuance is routine for a company of this size and does not signal a change in credit profile or financial strategy.

Key Facts

  • AstraZeneca priced €2.55 billion in Eurobonds across four tranches on 24 August 2026.
  • Tranches: €700M at 3.402% due 2030, €600M at 3.652% due 2032, €500M at 3.923% due 2035, €750M at 4.169% due 2038.
  • Issued by AstraZeneca Finance LLC and guaranteed by AstraZeneca PLC; expected to close 1 September 2026.
  • Net proceeds to be used for general corporate purposes.

Financial Impact

€2.55 billion in new debt issued; coupons range from 3.402% to 4.169% across maturities of 4 to 12 years.

debt

Risk Factors

  • Increased leverage from €2.55B in new debt, though manageable for a company of this scale.
  • Potential future interest rate exposure if floating-rate debt is added to the mix.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (35 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-007840
Document: 0001654954-26-007840-index-headers.html0001654954-26-007840
Document: 0001654954-26-007840-index.html0001654954-26-007840
Document: 0001654954-26-007840.txt0001654954-26-007840

Track record

77 reports on AZN

Performance horizon

19 of 38 bullish or bearish reports moved the stock their way by T+5. Best: +20.72% at T+60 after the Aug 17, 2026 report. 29 of 38 went positive at some point.

Filters
  1. Nov 16, 2026today 6-K Bullish 6/10 Entry price pending
  2. Nov 16, 2026today 6-K Bullish 6/10 Entry $185.55 Now $184.02 −0.82% settles Nov 23
  3. Nov 16, 2026today 6-K Bullish 6/10 Entry $185.31 Now $184.02 −0.70% settles Nov 23
  4. Nov 16, 2026today 6-K Bullish 5/10 Entry $185.09 Now $184.02 −0.58% settles Nov 23
  5. Nov 4, 202611d ago Institutional Cluster Mixed 3/10 Entry $186.85 to $184.38 Now $184.02 −1.51% ▼ −1.32% −4.61% vs SPY
  6. Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.02 −1.37% ▲ +1.51% +1.43% vs SPY
  7. Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.02 −1.37% ▲ +1.51% +1.43% vs SPY
  8. Oct 30, 202617d ago 6-K Neutral 5/10 Entry $186.65 to $186.43 Now $184.02 −1.41% ▼ −0.12% +2.59% vs SPY
  9. Oct 27, 202620d ago 6-K Bullish 5/10 Entry $170.08 to $183.88 Now $184.02 +8.20% ▲ +8.11% +10.10% vs SPY
  10. Oct 22, 202625d ago 6-K Bullish 6/10 Entry $172.57 to $173.46 Now $184.02 +6.63% ▲ +0.51% −0.19% vs SPY
Showing 10 of 77

US Market Status

Market Closed · Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 25, 2026